Do You Know The Significance of Prodrome Sciences for Our Health?

 


The ultimate goal of Prodrome sciences is to give people a blood test, identify which diseases they are at risk for, which biochemical systems are causing it, and then provide a mechanism for them to correct it. Experts wait until the result is revealed in our existing healthcare system, even when the disease is easily diagnosed. We're trying to warn people ahead of time.

So far, what prodromes have Dr. Dayan discovered?

We recently announced the commercialization of our Prodrome-CRC and Prodrome-PAC colon and pancreatic cancer programs, respectively. Later this year, ovarian cancer and Alzheimer's programs will be launched. However, we are working on many more, including autism, multiple sclerosis, Parkinson's disease, lung cancer, bipolar disorder, schizophrenia, etc.

What is the commercialization strategy entail?

It's the polar opposite of companion diagnostics. We have companion therapeutics, and some preventative medicine therapeutics are very inexpensive. That sounds good in public health, but it's difficult in terms of business.

In terms of diagnostic techniques, you could almost give the testing away for free because people would eventually pay for the drug. We can, however, do the opposite. Depending on the preventative measure, we can get paid for the testing and almost give the drug away for free.

For example, our healthcare system does not currently screen pancreatic cancer efficiently because the disease is uncommon, but our blood test changes that by making it simple to be tested. As a result, that type of diagnostic can enter the bloodstream without a therapeutic companion.

How is it different from Alzheimer's?

Alzheimer's is a little different. When we started working on the Alzheimer's program, doctors told us that having a diagnostic test for something you couldn't help treat was pointless. However, non-pharmacological prevention and treatment strategies have significantly improved Alzheimer's care over the last decade. People are now saying that our test would be extremely useful in the marketplace.

Clinical trials:

Yes, the most important aspect of Prodrome is that we apply a professional pharma and diagnostic industry mindset to preventative medicine, which has traditionally been the second cousin in the medical community. Supplement and related industries are big businesses that haven't been developed with the scientific zeal that traditional pharmaceutical markets have.

That is where we differ. We use large-scale clinical trials to determine and scientifically prove which of these precautionary medicines and strategies provide significant clinical benefits.

Dr. Dayan Goodenowe shares his knowledge through wonderful podcasts and videos. You may know about Alzheimer's through his book. If you're interested in bioscience or medical things, you should follow him for the knowledge of the Prodrome sciences.

Location: 40880 County Center Dr r, Temecula, CA 92591, USA

Comments

Post a Comment

Popular posts from this blog

Plasmalogens Supplements and Their Connection to Alzheimer's Disease

Image
  The development of mass spectrometry-based techniques has made it possible to compare the molecules that are changed during Alzheimer's disease. A constant decrease of plasmalogens is one of the modifications shown by this research. The varieties of phospholipids present in membranes are extremely diverse, and plasmalogens constitute a component of that vast terrain. Plasmalogens account for more than 20% of all phospholipids in humans, and they are especially abundant in the nervous system. Plasmalogen levels drop by up to 40% in Alzheimer's patients. The discovery of this large decrease in plasmalogens is critical in two areas of Alzheimer's disease: early detection and therapeutic intervention. First, these plasmalogen reductions might be effective indicators for detecting the development of Alzheimer's disease. Detecting plasmalogens levels has the benefit over other detection methods in that lower plasmalogens may be observed in blood and do not require costly an
Read more

Dr Dayan Goodenowe Discusses Plasmalogen Deficiency, Dementia, and Death.

Image
Plasmalogens are a subset of phospholipids. They concentrate on the brain and the heart. Plasmalogens is not just traced nutrients; they make up a significant portion of the brain, accounting for up to 20% of its dry weight. Plasmalogens serve as a storage site for essential fatty acids such as oleic acid, arachidonic acid, and docosahexaenoic acid (DHA). Plasmalogens are anti-inflammatory, powerful antioxidants, a critical component of cell membranes, lipoproteins, myelin, and synaptic membranes, and a major structural component of lipoproteins, myelin, and synaptic membranes. Plasmalogen levels in the brain rise until the age of 30 to 40, then fall precipitously by 70. There are insufficient food supplies. Plasmalogens are produced by the body in cell peroxisomes, with the liver producing the vast majority. The body's ability to produce plasmalogens hamper when peroxisome function deteriorates with age, and plasmalogens are destroyed due to inflammation and oxidative stress.
Read more